COVID-19 Crisis: Phase-II Human Trials For Bharat Biotech COVAXIN Vaccine To Begin In September

COVID-19 Crisis: Phase-II Human Trials For Bharat Biotech COVAXIN Vaccine To Begin In September

As India races against time to bring a safe and efficient anti-coronavirus vaccine made indigenously within the country, phase 1 of the human trials in most centres chosen for COVAXIN trials have concluded, India Today TV has learnt. The centres are now bracing for recruitment of candidates for phase 2 human trials, which are scheduled to begin in the first week of September.

Except for AIIMS Delhi – one of the 12 centres for the Bharat Biotech vaccine – where phase 1 trials are still underway, most of the other 11 centres have completed the process. AIIMS Delhi has only recruited 16 candidates for the vaccine human trials phase 1.

Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

Download Mobile App from India’s No.1 News Video Publisher : https://indiatoday.app.link/zKoSVVDrnP

Follow us: Official website: https://www.indiatoday.in/

Twitter: https://twitter.com/IndiaToday

Facebook: https://www.facebook.com/IndiaToday


Go to Source